British universities have launched the Synthetic Human Genome Project (SynHG) with an initial grant of approximately $12.6 ...

WalletHub compared all 50 states across affordability, quality of life, and healthcare metrics as 4 million Americans ...

Prothena slashes 63% of its workforce and axes birtamimab after trial failure, reshaping its pipeline and financial outlook. Shares plunge 53.5% YTD.

Central Lab Market Research, 2031 Logistics and sample handling are critical components of central lab services, and issues with these proc ...

A 2023 flood devastated Dalhousie’s medical research hub. Two years later, labs reopen, revealing a powerful story of ...

All too often, husbands don't know just how good they have it, and when that's the case, there are many things they seriously ...

VANCOUVER, BC / ACCESS Newswire / July 4, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that it has entered ...

A northern NSW man has died after being bitten by a bat, in the first confirmed case of Australian bat lyssavirus (ABLV) in ...

Interest in autonomous agents is skyrocketing. Here, CIOs from finance, retail, and healthcare discuss how they see the ...

Too much screen time in late childhood is associated with developmental changes in the brain, leading to more depressive ...

Summit Therapeutics nears a $15B AstraZeneca deal for ivonescimab, targeting a $90B market. See more on the potential and ...

Seasonal affective disorder (SAD) is commonly associated with autumn and winter months, but it can also emerge during the ...